HMVYX
Price
$18.27
Change
-$0.19 (-1.03%)
Updated
Oct 9 closing price
Net Assets
1.15B
JVMCX
Price
$27.67
Change
-$0.35 (-1.25%)
Updated
Oct 9 closing price
Net Assets
24.22B
Interact to see
Advertisement

HMVYX vs JVMCX

Header iconHMVYX vs JVMCX Comparison
Open Charts HMVYX vs JVMCXBanner chart's image
Hartford MidCap Value Y
Price$18.27
Change-$0.19 (-1.03%)
VolumeN/A
Net Assets1.15B
JHancock Disciplined Value Mid Cap C
Price$27.67
Change-$0.35 (-1.25%)
VolumeN/A
Net Assets24.22B
HMVYX vs JVMCX Comparison Chart in %
View a ticker or compare two or three
VS
HMVYX vs. JVMCX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVYX is a Hold and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.2B vs. HMVYX (1.15B). HMVYX pays higher dividends than JVMCX: HMVYX (0.79) vs JVMCX (0.00). HMVYX was incepted earlier than JVMCX: HMVYX (24 years) vs JVMCX (14 years). JVMCX (1.86) is less costly to investors than HMVYX (0.87). HMVYX is a more actively managed with annual turnover of: 132.00 vs. JVMCX (49.00). JVMCX has a lower initial minimum investment than HMVYX: JVMCX (1000) vs HMVYX (250000). JVMCX annual gain was more profitable for investors over the last year : -2.91 vs. HMVYX (-7.76). JVMCX return over 5 years is better than : 42.76 vs. HMVYX (34.30).
HMVYXJVMCXHMVYX / JVMCX
Total Expense Ratio0.871.8547%
Annual Report Gross Expense Ratio0.871.8647%
Fund Existence24 years14 years-
Gain YTD3.24410.75130%
Front LoadN/AN/A-
Min. Initial Investment250000100025,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B24.2B5%
Annual Yield % from dividends0.790.00-
Returns for 1 year-7.76-2.91266%
Returns for 3 years12.2727.0445%
Returns for 5 years34.3042.7680%
Returns for 10 years20.3240.9750%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GRN31.530.02
+0.06%
iPath® Series B Carbon ETN
LFAZ163.72N/A
N/A
LifeX 2062 Longevity Income ETF
IBMP25.40-0.02
-0.08%
iShares iBonds Dec 2027 Term Muni Bd ETF
FDL42.96-0.26
-0.60%
First Trust Morningstar Div Leaders ETF
PSCH42.26-0.35
-0.82%
Invesco S&P SmallCap Health Care ETF